Clinical, histological and molecular characteristics of Alport syndrome in Chinese children
- PMID: 37097554
- DOI: 10.1007/s40620-023-01570-7
Clinical, histological and molecular characteristics of Alport syndrome in Chinese children
Abstract
Background: Alport syndrome is caused by COL4A3, COL4A4, or COL4A5 gene mutations. The present study aims to compare the clinicopathological features, gene mutations, and outcome of Chinese children with different forms of Alport syndrome.
Methods: One hundred twenty-eight children from 126 families diagnosed with Alport syndrome through pathological and genetic examination between 2003 and 2021 were included in this single-center retrospective study. The laboratory and clinicopathological features of the patients with different inheritance patterns were analyzed. The patients were followed-up for disease progression and phenotype-genotype correlation.
Results: Of the 126 Alport syndrome families, X-linked forms accounted for 77.0%, autosomal recessive for 11.9%, autosomal dominant for 7.1%, and digenic for 4.0%. Among the patients, 59.4% were males and 40.6% were females. Altogether, 114 different mutations were identified in 101 patients from 99 families by whole-exome sequencing, of which 68 have not been previously reported. The most prevalent type of mutation was glycine substitution, which was identified in 52.1%, 36.7%, and 60% of the patients with X-linked Alport syndrome, autosomal recessive and autosomal dominant Alport syndrome, respectively. At the end of a median follow up of 3.3 (1.8-6.3) years, Kaplan-Meier curves showed kidney survival was significantly lower in autosomal recessive compared to X-linked Alport syndrome (P = 0.004). Pediatric patients with Alport syndrome seldom presented extrarenal involvement.
Conclusions: X-linked Alport syndrome is the most frequent form found in this cohort. Progression was more rapid in autosmal recessive than in X-linked Alport syndrome.
Keywords: Alport syndrome; Gene mutation; Genotype–phenotype correlation; Kidney biopsy; Pediatrics.
© 2023. The Author(s) under exclusive licence to Italian Society of Nephrology.
Similar articles
-
Alport syndrome. Molecular genetic aspects.Dan Med Bull. 2009 Aug;56(3):105-52. Dan Med Bull. 2009. PMID: 19728970
-
Genetic study of Alport syndrome in Tunisia.Pediatr Nephrol. 2025 Jan;40(1):103-116. doi: 10.1007/s00467-024-06474-7. Epub 2024 Aug 14. Pediatr Nephrol. 2025. PMID: 39138691
-
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.Kidney Int. 2004 May;65(5):1598-603. doi: 10.1111/j.1523-1755.2004.00560.x. Kidney Int. 2004. PMID: 15086897
-
Digenic Alport Syndrome.Clin J Am Soc Nephrol. 2022 Nov;17(11):1697-1706. doi: 10.2215/CJN.03120322. Epub 2022 Jun 8. Clin J Am Soc Nephrol. 2022. PMID: 35675912 Free PMC article. Review.
-
Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.Pediatr Nephrol. 2020 Jan;35(1):59-66. doi: 10.1007/s00467-018-4121-1. Epub 2018 Nov 30. Pediatr Nephrol. 2020. PMID: 30506145 Review.
Cited by
-
Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria.Ren Fail. 2024 Dec;46(2):2423845. doi: 10.1080/0886022X.2024.2423845. Epub 2024 Nov 14. Ren Fail. 2024. PMID: 39540369 Free PMC article.
References
-
- Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF (1986) Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds withAlport-type familial nephritis. J Clin Invest 78:1035–1044. https://doi.org/10.1172/jci112658 - DOI - PubMed - PMC
-
- McCoy RC, Johnson HK, Stone WJ, Wilson CB (1982) Absence of nephritogenic gbm antigen(s) in some patients with hereditary nephritis. Kidney Int 21:642–652. https://doi.org/10.1038/ki.1982.72 - DOI - PubMed
-
- Horinouchi T, Yamamura T, Minamikawa S, Nagano C, Sakakibara N, Nakanishi K et al (2020) Pathogenic evaluation of synonymous col4a5 variants in x-linked Alport syndrome using a minigene assay. Mol Genet Genomic Med 8:e1342. https://doi.org/10.1002/mgg3.1342 - DOI - PubMed - PMC
-
- Kruegel J, Rubel D, Gross O (2013) Alport syndrome–insights from basic and clinical research. Nat Rev Nephrol 9:170–178. https://doi.org/10.1038/nrneph.2012.259 - DOI - PubMed
-
- Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T et al (2019) A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23:158–168. https://doi.org/10.1007/s10157-018-1629-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources